Nephrology Flashcards
Causes of RAISED anion gap metabolic acidosis:
'LUKA' Lactate: Shock, hypoxia Ketones: DKA, alcohol Urate: Renal failure Acid poisoning: salicylates, methanol
Metabolic acidosis with NORMAL anion gap:
'BRAAD" Bicarbonate loss (diarrhoea, fistula) Renal tubular acidosis Ammonium chloride injection Addison's disease Drugs (acetazolamide)
Vomiting/aspiration Diuretics Hypokalaemia Primary hyperaldosteronism Cushing's syndrome Congenital adrenal hyperplasia
Cause which biochemical imbalance?:
Metabolic alkalosis
Acute interstitial nephritis:
Drug causes:
ANTIBIOTICS -> Penicillin, rifampicin, NSAIDs, Allopurinol, furosemide
Acute intersitital nephritis presentation
AKI w/ fever, rash, arthralgia with eosinophilia and mild renal impairment:
Feature of CKD less likely to be seen in AKI?
Hypocalcaemia
Bilateral small kidneys:
CKD
Oligruria output:
Less than 0.5 ml/kg/hour
AKI criteria:
Rise in SERUM CREATININE of 26mmol/l within 48 hours
50% or greater rise in serum creatinine in the last 7 days
Fall in urine output to <0.5 ml/kg/hour in 6 hours
What test should all pts. with suspected AKI have:
Urinalysis
Drugs to stop in AKI:
the DAAMN drugs
Diuretics
ACEis/ARBS
Aminoglycosides
Metformin (Maybe) - doesn’t contribute to toxicity itself but may worsen AKI
NSAIDS (except asprin at cardioprotective dose)
Hyperkalaemia tx:
Calcium cluconate (stabilise cardiac membrane)
Insuline/dextrose infusion
Nebulised salbutamol
Calcium resonium, loop diuretics, dialysis (to remove)
Indications for dialaysis in AKI/hyperkalaemia
Tx. not working resulting in
Pulmonary oedema, acidosis, uraemia or refractory hyperkalaemia
What do the kidneys attempt to do to preserve volume in PRE-renal AKI -
Keep sodium
KDIGO criteria for staging AKI
Stage 1: 1.5-2 times baseline increase in CREATININE
Urine output reduced to <0.5mL/kg/hour > 6 hours
Stage 2: 2 to 3 times CREATININE
Urine output reduced to <0.5mL/kg/hour > 12 hours
Stage 3: Greater than 3 times CREATININE or to 353.6 umol/L
Urine output reduced to <0.3mL/kg/hour > 24 hours
Mx. ADPKD
Select patients: Tolvaptan (vasopressin receptor 2 antagonist)
Hypertension with recurrent UTIs, haematuria
ADPKD
Cardiovascular features of ADPKD
Mitral valve prolapse
Mitral/tricuspid incompetence
Aortic root dilation
Alport’s inheritance:
Type of collagen affected:
X-linked dominant
Type IV
Bilateral sensorineural deafness plus microscopic haematuria and renal failure:
Alport’s disease
Diagnostic test for Alport’s
Renal biopsy and genetic testing
Congo red staining: apple-green birefringence
Amyloidosis
Anti-GBM disease mx:
Plasma exchange (plasmapharesis)
Steroids
cyclophosphamide
CKD anaemia classification
Usually a normocytic normochromic anaemia
due to reduced EPO levels
CKD: calcium and phosphate levels:
Low calcium high phosphate
CKD stages
1) GFR >90 w/ other abnormal kidney tests
2) GFR 60-90 w/ other abnormal kidney tests
3a) 45-60
3b) 30-45
4) 15-29 - severe functional impairment
5) <15
First line antihypertensive in pts. w/ CKD
What effect on eGFR/Cr is acceptable
ACEIs
eGFR reduction of 25% or rise in Cr of 30% deemed acceptable
First line antihypertensive in pts. w/ CKD
What effect on eGFR/Cr is acceptable
ACEIs
eGFR reduction of 25% or rise in Cr of 30% deemed acceptable
CKD: Mineral bone disease management
Aim is to to reduce phosphate and parathyroid hormones
1st line: REDUCE intake of dietary phosphate.
Phosphate binders
Vit D: alfacalcidol
May require parathyroidectomy
ACR of 30 mg/mmol is equivalent to:
PCR ->
Urinary protein excretion
50
0.5 g/day